n17350
onchilles pharma
['n17350']
sdbn feed: onchilles pharma presents at aacr 2023 new preclinical data on n17350, a first-in-class immuno-oncology drug candidate with broad, potent, and direct tumor killing activity: san diego &amp; orlando, ... #sandiego #biotech 
San Diego Biotech Networks: Building a community and providing #lifescience news, jobs, events. Founding org of @BiotechNetworks. For jobs follow @sdbnjobs.